Management of hyperlipidemia among patients with rheumatoid arthritis in the primary care setting

BMC Musculoskeletal Disorders
Kashif JafriAlexis Ogdie

Abstract

Rheumatoid arthritis (RA) has been associated with an increased risk of cardiovascular morbidity and mortality but this has not translated to optimal management of traditional cardiovascular risk factors such as hyperlipidemia. The objectives of this study were to 1) determine the prevalence of screening for hyperlipidemia in patients with RA followed by primary care practitioners (PCP); 2) examine initiation of lipid-lowering therapy in patients with an indication, and 3) assess whether proposed modifications to cardiovascular risk calculations change the percentage of RA patients with an indication for therapy. We performed a retrospective cohort study using an academic medical center-based medical record database in the United States. Patients with RA defined by the presence of at least one ICD-9 code between 2005-2010 and followed by a PCP within the health care system were included. The positive predictive value of ICD-9 codes for accurately identifying patients with RA was 96.7%. Descriptive statistics were used to report the prevalence of screening and use of lipid-lowering therapy among those with an indication. Factors associated with not receiving lipid screening were examined using logistic regression models. Indicat...Continue Reading

References

May 29, 1998·Circulation·P W WilsonW B Kannel
Apr 4, 2006·Current Opinion in Rheumatology·Mariana J Kaplan
Jun 24, 2006·Annals of the Rheumatic Diseases·D H SolomonS Schneeweiss
Nov 28, 2008·Arthritis and Rheumatism·J Antonio Aviña-ZubietaDiane Lacaille
Jul 18, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Kimon S StamatelopoulosPetros P Sfikakis
Feb 3, 2011·JAMA : the Journal of the American Medical Association·Gabriela SchmajukJinoos Yazdany
Feb 10, 2011·Arthritis and Rheumatism·Christie M BartelsMaureen Smith
Apr 19, 2011·Current Opinion in Cardiology·Holly JohnGeorge D Kitas
Jun 2, 2011·Nature Reviews. Rheumatology·Deborah P M Symmons, Sherine E Gabriel
Apr 24, 2012·The American Journal of Cardiology·Cynthia S CrowsonSherine E Gabriel
Oct 2, 2012·Annual Review of Medicine·J Michelle Kahlenberg, Mariana J Kaplan
May 3, 2013·The Journal of Rheumatology·Bharath Manu Akkara VeetilCynthia S Crowson
Aug 24, 2013·Arthritis Research & Therapy·Carmen Gómez-VaqueroMiguel A González-Gay

❮ Previous
Next ❯

Citations

Jun 17, 2018·Rheumatology International·Luísa Lima CastroRosa Weiss Telles
Jun 12, 2020·Rheumatology International·Aliki I VenetsanopoulouAlexandros A Drosos
Dec 21, 2016·Arthritis Care & Research·Jessica WiddifieldKaren Tu
Mar 29, 2020·Journal of the American College of Cardiology·Ijeoma Isiadinso
Apr 13, 2020·JACC. Heart Failure·Sameer PrasadaMatthew J Feinstein

❮ Previous
Next ❯

Software Mentioned

EULAR

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.